全部成果分类

导出
  • 排序
  • 显示
3. Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial PubMed SCOPUS

作者:Wu Y.-L.; Lu S.; Cheng Y.; Zhou C.; Wang J.; Mok T.; Zhang L.; Tu H.-Y.; Wu L.; Feng J.; Zhang Y.; Luft A.V.; Zhou J.; Ma Z.; Lu Y.; Hu C.; Shi Y.; Baudelet C.; Cai J.; Chang J.

作者机构:[Wu, Y.-L] Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guan 更多

关键词:Chinese population; Nivolumab; NSCLC; Phase III clinical study

来源:Journal of Thoracic Oncology,2019,Vol.14,Issue.5

Scopus被引频次:1

资源类型:外文期刊论文

8. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression SCIE

作者:Qinnan, C; Zhaoxia, W

作者机构:[Qinnan, C.; Zhaoxia, W.] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.

来源:JOURNAL OF THORACIC ONCOLOGY,2018,Vol.13,Issue.4

ESI学科:CLINICAL MEDICINE

最新一期影响因子:6.595

资源类型:外文期刊论文

9. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell progression by silencing of P21 expression SCIE

作者:Zhenyao, C; Xin, C; Zhaoxia, W

作者机构:[Zhenyao, C.; Xin, C.; Zhaoxia, W.] Nanjing Med Univ, Affiliated Hosp 2, Oncol, Nanjing, Jiangsu, Peoples R China.

来源:JOURNAL OF THORACIC ONCOLOGY,2018,Vol.13,Issue.4

ESI学科:CLINICAL MEDICINE

最新一期影响因子:6.595

资源类型:外文期刊论文

共 3 页, 55 条记录

TOP